BioSpace News Archive

RT-100 AC6 gene transfer involves infusing an inactivated adenovirus vector encoding human adenylyl cyclase type 6 into the arteries that feed the heart during cardiac catheterization, a commonly performed procedure.

NeuX Technologies and Muscle Activation Technique announced the execution of a Letter of Intent for a Strategic Alliance focused on exploring and developing solutions for the treatment and prevention of musculoskeletal conditions that result in chronic pain, limited range of motion and less than optimal performance in daily and athletic activities.

Jecure Therapeutics announced that Gretchen Bain, Ph.D., has joined the company as its Vice President of Biology.

The agreement highlights the two companies’ shared focus on antibiotic stewardship and preventing sepsis in hospital care settings by delivering better solutions for healthcare providers to fight infections and their often-deadly complications.

BioVectra today announced a long-term supply agreement with Keryx Biopharma to manufacture Ferric Citrate, the API in Auryxia tablets.

Mr. Kucheman brings a breadth of experience to Cibiem.

his pilot study will test the effect of an innovative, proprietary device, which emits electrical pulses through the patient’s ear five minutes a day for four days.

In this expanded role, Lacouture will drive growth of the company’s sustainable process for large-scale production of natural silk in liquid form, while maintaining her position as COO and a member of the board of directors.

Executive Director John O. “Jack” Snyder is retiring after more than 24 years with the organization.

Exofin Fusion is a a new skin closure system to treat medium to large wounds.